Back to search

University of Glasgow

Cardiovascular effects of serotonergic agents

Abstract

dc:description.abstract

Serotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter which exerts its cardiovascular effects predominantly by interaction with specific 5-HT1 and 5- HT2 receptors. The effects of serotonergic agents differ between in vivo and in vitro preparations and display wide inter-species variation. It is therefore impossible to extrapolate results from animal or in vitro studies to the clinical situation. The role of these two receptors has therefore been studied in patients with suspected coronary artery disease using 3 different 5-HT1 agonists and ketanserin, a 5-HT2 antagonist. Sumatriptan and naratriptan, 5-HT1B/D receptor agonists, vasoconstrict the systemic and pulmonary circulations. Sumatriptan-induced vasoconstriction appears more pronounced in the pulmonary circulation suggesting a greater density of 5-HT1 receptors in the pulmonary compared to the systemic circulation. Although left ventricular end diastolic pressure and pulmonary artery wedge pressure rose after sumatriptan, there was no change in peak rate of left ventricular pressure rise, indicating the absence of a negative inotropic action. Naratriptan, an analogue of sumatriptan, displayed no significant effect on coronary artery diameter, a finding previously noted with sumatriptan. Eletriptan, a selective 5-HT1D agonist with less 5-HT1B activity, had little vasoconstrictor effect on the systemic, pulmonary or coronary circulation perhaps suggesting that the 5-HT1B receptor subtype mediates vasoconstriction. The effect of sumatriptan on systolic time intervals and forearm blood flow was also assessed. The results suggest that STI's are of potential use in the non-invasive assessment of 5-HT1 agonists. No significant effect on forearm blood flow was observed but plasma noradrenaline levels fell after subcutaneous sumatriptan. Ketanserin, a 5-HT2 antagonist, acted as a vasodilator in the systemic and pulmonary circulation but failed to vasodilate the coronary arteries, presumably because the patients in this study had stable angina without platelet activation and therefore had low circulating levels of serotonin.

Degree

thesis:*
Level dc:type.qualificationlevel
MD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
1999

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hood, Stuart Hugh Macpherson

Subjects

dc:subject × 1

Rights

Language dc:language
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Hood, Stuart Hugh Macpherson. Cardiovascular effects of serotonergic agents. MD thesis, University of Glasgow, 1999. https://doi.org/10.5525/gla.thesis.71687